News & Updates

In patients with paroxysmal atrial fibrillation, the presence of comorbidities is associated with lower left and right atrial strain, a recent study has found.

Systolic blood pressure (BP) levels in people in their early 40s are independently related to left atrial volumes in their mid‐60s, with greater BP being relevant for left atrial remodelling later in life, according to a study.

The use of statins helps reduce all-cause mortality in patients with atherosclerotic cardiovascular disease, especially in the first 6 months after an event, reports a recent study.

Brain metastasis usually develops in patients with cardiac angiosarcoma (CA), and their risk of intracranial haemorrhage (IH) is high, results of a study have shown. This leads to an alarming rate of terminal haemorrhage (TH) despite normal platelet counts.

One year after undergoing percutaneous coronary intervention (PCI), high-risk patients on clopidogrel monotherapy have a reduced risk of multiple cardiovascular (CV) outcomes compared with those on aspirin monotherapy, according to a study presented at SCAI 2022.

In the Disrupt PAD III trial, superior primary patency (PP) was achieved at 1 year with intravascular lithotripsy (IVL) plus a drug-coated balloon (DCB) compared with percutaneous transluminal angioplasty (PTA) + DCB, confirming the consistent safety and efficacy of IVL to facilitate a durable approach for individuals with heavily calcified femoropopliteal arteries largely without stent requirement.

In an expanded analysis presented at SCAI 2022, recipients of the Harmony transcatheter pulmonary valve (TPV) continued to demonstrate favourable clinical and haemodynamic outcomes, confirming previous results and showing continued device success across studies and valve types at 1 year and beyond.